DEVELOPMENT OF THYROIDAL SUPPRESSION BY TRIIODOTHYRONINE DURING 6 MONTHS TREATMENT OF THYROTOXICOSIS WITH ANTITHYROID DRUGS

被引：38
|
作者：
ALEXANDER, WD
HARDEN, RM
SHIMMINS, J
MCLARTY, D
MCGILL, P
机构：
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1967年 / 27卷 / 12期
关键词：
D O I：
10.1210/jcem-27-12-1682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1682 / +
页数：1
相关论文
共 50 条
  • [21] Prolonged Treatment With Antithyroid Drugs How Long to Treat Safely ... Months, Years, or a Lifetime?
    Nelson, Peggy
    Gossain, Ved V.
    ENDOCRINOLOGIST, 2010, 20 (05): : 217 - 219
  • [22] CLINICAL VALUE OF SERUM TRIIODOTHYRONINE, THYROXINE AND THYROTROPIN ESTIMATIONS DURING MEDICAL ANTITHYROID TREATMENT
    ROGOWSKI, P
    FRIIS, T
    KIRKEGAARD, C
    SIERSBAEKNIELSEN, K
    ACTA MEDICA SCANDINAVICA, 1977, 202 (1-2): : 93 - 96
  • [23] THE INCIDENCE OF RECURRENCE AND HYPOTHYROIDISM FOLLOWING TREATMENT WITH ANTITHYROID DRUGS, SURGERY OR RADIOIODINE IN ALL PATIENTS WITH THYROTOXICOSIS IN MALMO DURING THE PERIOD 1970-1974
    BERGLUND, J
    CHRISTENSEN, SB
    DYMLING, JF
    HALLENGREN, B
    JOURNAL OF INTERNAL MEDICINE, 1991, 229 (05) : 435 - 442
  • [24] SUPPRESSIBILITY OF THYROID FUNCTION DURING TREATMENT WITH ANTITHYROID DRUGS IN GRAVES DISEASE
    WILS, JA
    KLOPPENBORG, PW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (03): : 406 - +
  • [25] DEVELOPMENT OF CUSHINGS DISEASE DURING 6 MONTHS TREATMENT WITH AN OVULATION INHIBITOR
    WINKLER, G
    BAHNER, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 97 (50) : 1696 - &
  • [26] Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to graves disease - A novel side effect of antithyroid drugs
    Suzuki, S
    Ichikawa, K
    Nagai, M
    Mikoshiba, M
    Mori, J
    Kaneko, A
    Sekine, R
    Asanuma, N
    Hara, M
    Nishii, Y
    Yamauchi, K
    Aizawa, T
    Hashizume, K
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (06) : 693 - 696
  • [27] COMPARISON OF TRIIODOTHYRONINE SUPPRESSION TEST BY 20-MINUTE AND 24-HOUR THYROIDAL I-131 UPTAKE IN PATIENTS RECEIVING THIOAMIDE DRUGS
    NAGATAKI, S
    UCHIMURA, H
    MATSUZAKI, F
    MASUYAMA, Y
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (02): : 255 - 261
  • [28] INCREASED SERUM INTERLEUKIN-1-BETA DURING TREATMENT OF HYPERTHYROIDISM WITH ANTITHYROID DRUGS
    TSATSOULIS, A
    VLACHOYIANNOPOULOS, PG
    DALEKOS, GN
    JOHNSON, EO
    MOUTSOPOULOS, HM
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (09) : 654 - 658
  • [29] RECOVERY OF INITIALLY SUPPRESSED THYROIDAL RADIOIODINE UPTAKE DURING LONG-TERM ANTITHYROID TREATMENT OF EUTHYROID VOLUNTEERS AND HYPERTHYROID PATIENTS
    STUDER, H
    ROHNER, R
    KONIG, MP
    LIPS, B
    LEMARCHA.T
    BUCHER, HJ
    KOHLER, H
    ACTA ENDOCRINOLOGICA, 1972, 70 (04): : 697 - &
  • [30] SERUM THYROGLOBULIN (TG) LEVEL AS A PREDICTOR OF RELAPSE FOLLOWING TREATMENT OF GRAVES-DISEASE WITH ANTITHYROID DRUGS AND TRIIODOTHYRONINE (T3)
    HARVEY, RD
    HIMSWORTH, RL
    TAYLOR, G
    SCOTTISH MEDICAL JOURNAL, 1987, 32 (06) : 190 - 190
12345